[Clinical effectiveness of palpitin in treating heart rhythm disorders in ischemic heart disease patients].
Clinical efficiency of the antiarrhythmic agent palpitin used for the treatment of ventricular and supraventricular extra-systole was assessed in 94 coronary patients, using Holter's ECG monitoring, electrophysiologic studies and rheographic control; reliable evidence in favor of the drug high antiarrhythmic efficiency was obtained.
D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D004206:Disopyramide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D006329:Heart Conduction System / Q000187:drug effects / Q000503:physiopathology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D004206:Disopyramide
Klinicheskaia éffektivnost' pal'pitina pri lechenii narusheniĭ serdechnogo ritma u bol'nykh ishemicheskoĭ bolezn'iu serdtsa.